Checkout
Cart: $0.00 - (0 items )

Compass Pathways Reports Positive Results From Psilocybin Study

The mental health care company COMPASS Pathways reported Thursday that its its COMP350 (psilocybin) was well-tolerated by healthy volunteers …

Read the full article at: www.benzinga.com

RECENT POSTS

Back to top